We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Notch Signaling Activity Controls Muscle Regeneration

By Biotechdaily staff writers
Posted on 10 Dec 2003
Researchers into aging have found that the Notch signaling pathway is critically involved in the decreased ability of muscles to regenerate after injury in older individuals.

The Notch signaling pathway is an evolutionarily highly conserved system for cell-cell communication, which exists in most if not all multicellular species. More...
Notch receptors undergo a complex set of proteolytic processing events in response to ligand activating, which eventually leads to release of the intracellular domain of the receptor.


Investigators at Stanford University (Palo Alto, CA, USA) worked with a mouse model to examine the effect of the Notch pathway in muscle satellite cells. They found that the cells from older mice (equivalent to a 70-year-old human) did not reproduce as rapidly as those from younger animals, and that this was due to a decrease in synthesis of the Notch protein Delta.


They reported in the November 28, 2003, issue of Science that they could slow muscle regeneration in young cells by inhibiting Notch activity. On the other hand, older cells could be rejuvenated by treatment with a molecule that mimicked the activity of the Delta protein.

"What you really want to do is maintain the youthfulness of the regeneration pathway,” said senior author Dr. Thomas Rando, associate professor of neurology and neurological sciences at Stanford University. "If you presume that normal muscle bulk is maintained by gradual replacement of muscle tissue by satellite cells and that gradual replacement is diminished in older people, that would lead to atrophy. Figuring out atrophy in one of the pathways could relate to the others.”




Related Links:
Stanford University

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Clinical Chemistry Assay
Sorbitol Dehydrogenase (SDH)
Immunofluorescence Analyzer
IFA System
CMV CLIA Diagnostic
CLIA CMV IgA Screen Group
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Alzheimer’s pathology can start 15 to 20 years before symptoms, and validated tools that reach patients earlier help pave the way for earlier detection. (Image Credit: Adobe Stock)

Alzheimer’s Blood Test Becomes First FDA-Cleared Option for Adults as Young as 40

C2N Diagnostics’ PrecivityAD2 blood test was cleared by the U.S. Food and Drug Administration (FDA) on August 20, 2026, for adults as young as 40 who are experiencing signs of cognitive impairment, according... Read more

Pathology

view channel
Image: Adrenal gland tumor stained with hematoxylin and eosin (top) and CYP11B2 (bottom) (Photo courtesy of Christofer Juhlin)

Simple Immunohistochemical Size Ratio Improves Classification of Primary Aldosteronism

Primary aldosteronism is a common but underdiagnosed cause of hypertension, in which excess aldosterone promotes salt retention and raises blood pressure. Identifying the dominant source of hormone overproduction... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.